Royal Philips Releases Annual Report 2024
Royal Philips (NYSE: PHG, AEX: PHIA), a prominent name in health technology, has recently published its Annual Report for 2024. This comprehensive report showcases the company’s commitment to enhancing people's health and well-being through innovation and advanced technologies.
Key Highlights of the Annual Report
The Annual Report 2024 includes significant updates on key areas such as financial performance and strategic plans for future growth. This report is a critical part of the agenda for the upcoming Annual General Meeting of Shareholders (AGM), scheduled for May 8, 2025, where shareholders will have the opportunity to review and discuss the report in detail.
Financial Overview
Philips generated sales of EUR 18.0 billion in 2024, highlighting strong performance across multiple sectors. With around 67,800 employees, Philips operates in over 100 countries, providing both personal health solutions for consumers and professional health services for healthcare providers.
Shareholder Engagement
The Annual Report 2024 also emphasizes Philips' dedication to transparency and shareholder engagement. The report will be available in the European Single Electronic Format (ESEF) and will be filed with the Netherlands Authority for the Financial Markets (AFM) and the U.S. Securities and Exchange Commission. Shareholders can access the report online and request a printed copy free of charge, ensuring wide access to this key document.
Philips' Innovation and Technology Focus
Philips prides itself on being at the forefront of health technology innovation. The company leverages advanced technology and deep clinical insights to develop solutions that meet the needs of patients and healthcare professionals alike. From diagnostic imaging to telehealth solutions, Philips is continually enhancing its offerings to improve health outcomes.
Commitment to Health Solutions
Philips is not only focused on innovation but also on ensuring that it provides meaningful health solutions that improve lives. The company emphasizes a patient-centered approach, which reflects its goal to advance healthcare practices and outcomes in both hospital and home settings.
Contact Information for Investors
For any inquiries related to the Annual Report or Philips' financial performance, shareholders and interested parties are encouraged to reach out to:
Elco van Groningen
Philips Global External Relations
Tel.: +31 68103 9584
E-mail: elco.van.groningen@philips.com
Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com
Frequently Asked Questions
What is the purpose of the Annual Report 2024?
The Annual Report 2024 outlines Royal Philips' financial performance, strategic goals, and innovations in health technology.
When will the AGM take place?
The Annual General Meeting of Shareholders is scheduled for May 8, 2025.
How can shareholders access the Annual Report?
The report will be available online and shareholders can request a printed copy free of charge.
What are the financial highlights from the report?
Philips generated sales of EUR 18.0 billion in 2024, reflecting a strong performance across various sectors.
Who can I contact for more information?
Contact Elco van Groningen for external relations or Dorin Danu for investor relations at Philips.
